Recognizing how persistent depressive disorder manifests and plays out in the lives of individuals is the first step in ...

Dynamic interpersonal therapy (DIT) is a short-term psychodynamic psychotherapy that has been shown to effectively reduce depressive symptoms in patients with major depressive disorder (MDD). In DIT, ...

Solriamfetol is a dopamine and norepinephrine reuptake inhibitor, trace amine-associated receptor 1 agonist, and 5-HT 1A agonist. It is currently approved under the brand name Sunosi ® to improve ...

Unlike standalone MDD, where depressive episodes come and go, or PDD, which lingers at a lower intensity, double depression ...

Study finds AI chatbot significantly improve symptoms for those suffering from major depressive disorder (MDD), generalized ...

In this article, we look at how this condition develops, who might be at risk, and the available treatment options. People with SAD, or major depressive disorder with seasonal pattern, experience ...

Axsome Therapeutics (AXSM) announced results of the PARADIGM Phase 3 proof-of-concept trial of solriamfetol in major depressive disorder, MDD, ...

A week after reporting a successful phase 3 trial of Sunosi (solriamfetol) in patients with attention-deficit/hyperactivity ...

Discover the 6 types of depression affecting millions of Americans, their causes, warning signs, and effective treatments ...

The research team believes that AI treatment chatbots have the potential to provide large-scale customized mental health ...

The Horizon 3.0 TMS Therapy System is a computerized, noninvasive medical device that directs electrical currents at different regions of the cerebral cortex.